Search research articles
Contact Us
Filters
Showing results (141-150 of 269) with videos related to
Page
of 27
Sort By:
Journal of Lipid Research
|
August 1, 1989
Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteinemia
T Kuusi, C Ehnholm, J Viikari, et al.
European Journal of Clinical Investigation
|
December 13, 1997
The Asn-291-->Ser and Ser-477-->Stop mutations of the lipoprotein lipase gene and their significance for lipid metabolism in patients with hypertriglyceridaemia
P Knudsen, S Murtomäki, M Antikainen, et al.
Journal of Lipid Research
|
April 1, 1996
Heterozygosity for Asn291-->Ser mutation in the lipoprotein lipase gene in two Finnish pedigrees: effect of hyperinsulinemia on the expression of hypertriglyceridemia
M Syvänne, M Antikainen, S Ehnholm, et al.
Atherosclerosis
|
February 10, 1997
In vivo metabolism of apo A-I and apo A-II in subjects with apo A-I(Lys107-->0) associated with reduced HDL cholesterol and Lp(AI w AII) deficiency
M Tilly-Kiesi, C J Packard, J Kahri, et al.
Cardiovascular Diabetology
|
August 23, 2005
Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481]
R Scott, J Best, P Forder, et al.
Atherosclerosis
|
November 1, 1988
XbaI and c/g polymorphisms of the apolipoprotein B gene locus are associated with serum cholesterol and LDL-cholesterol levels in Finland
K Aalto-Setälä, M J Tikkanen, M R Taskinen, et al.
Diabetes Care
|
September 10, 1999
Chronic complications in patients with slowly progressing autoimmune type 1 diabetes (LADA)
B Isomaa, P Almgren, M Henricsson, et al.
Diabetologia
|
December 29, 2000
Differences in HDL-cholesterol:apoA-I + apoA-II ratio and apoE phenotype with albuminuric status in Type I diabetic patients
S S Soedamah-Muthu, H M Colhoun, M R Taskinen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
September 13, 2001
Metabolic effects of metformin in patients with impaired glucose tolerance
M Lehtovirta, B Forsén, M Gullström, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
September 1, 1995
ApoA-IHelsinki (Lys107-->0) associated with reduced HDL cholesterol and LpA-I:A-II deficiency
M Tilly-Kiesi, Q Zhang, S Ehnholm, et al.
Page
of 27
Search research articles
Search
Showing results (141-150 of 269) with videos related to
Sort By:
Page
of 27
Journal of Lipid Research
|
August 1, 1989
Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteinemia
T Kuusi, C Ehnholm, J Viikari, et al.
European Journal of Clinical Investigation
|
December 13, 1997
The Asn-291-->Ser and Ser-477-->Stop mutations of the lipoprotein lipase gene and their significance for lipid metabolism in patients with hypertriglyceridaemia
P Knudsen, S Murtomäki, M Antikainen, et al.
Journal of Lipid Research
|
April 1, 1996
Heterozygosity for Asn291-->Ser mutation in the lipoprotein lipase gene in two Finnish pedigrees: effect of hyperinsulinemia on the expression of hypertriglyceridemia
M Syvänne, M Antikainen, S Ehnholm, et al.
Atherosclerosis
|
February 10, 1997
In vivo metabolism of apo A-I and apo A-II in subjects with apo A-I(Lys107-->0) associated with reduced HDL cholesterol and Lp(AI w AII) deficiency
M Tilly-Kiesi, C J Packard, J Kahri, et al.
Cardiovascular Diabetology
|
August 23, 2005
Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481]
R Scott, J Best, P Forder, et al.
Atherosclerosis
|
November 1, 1988
XbaI and c/g polymorphisms of the apolipoprotein B gene locus are associated with serum cholesterol and LDL-cholesterol levels in Finland
K Aalto-Setälä, M J Tikkanen, M R Taskinen, et al.
Diabetes Care
|
September 10, 1999
Chronic complications in patients with slowly progressing autoimmune type 1 diabetes (LADA)
B Isomaa, P Almgren, M Henricsson, et al.
Diabetologia
|
December 29, 2000
Differences in HDL-cholesterol:apoA-I + apoA-II ratio and apoE phenotype with albuminuric status in Type I diabetic patients
S S Soedamah-Muthu, H M Colhoun, M R Taskinen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
September 13, 2001
Metabolic effects of metformin in patients with impaired glucose tolerance
M Lehtovirta, B Forsén, M Gullström, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
September 1, 1995
ApoA-IHelsinki (Lys107-->0) associated with reduced HDL cholesterol and LpA-I:A-II deficiency
M Tilly-Kiesi, Q Zhang, S Ehnholm, et al.
Page
of 27